bb21217
bluebird bio
day 3 #ims2022 oral abstract session nct03274219 : phase 1 - bb21217 an anti-bcma car t cell drug product, in rrmm - crb-402 #mmsm #multiplemyeloma #curemyeloma 
Multiple Myeloma Education Platform for Myeloma Community